Newman Dignan & Sheerar, Inc. Abbott Laboratories Transaction History

Newman Dignan & Sheerar, Inc.

$457 Million
Q3 2025

A detailed history of Newman Dignan & Sheerar, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 5,097 shares of ABT stock, worth $662,762. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,097

Previous 4,917 3.66%

Holding current value

$662,762

Previous $668,000 2.1%

% of portfolio

0.15%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 09, 2025	BUY	$120.51 - $136.62 $21,691 - $24,591	180 Added 3.66%	5,097 $682,000
Q2 2025 Jul 18, 2025	BUY	$123.95 - $138.08 $1,363 - $1,518	11 Added 0.22%	4,917 $668,000
Q1 2025 May 14, 2025	BUY	$111.1 - $140.22 $1,555 - $1,963	14 Added 0.29%	4,906 $650,000
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $4,603 - $5,433	46 Added 0.95%	4,892 $557,000
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $6,043 - $6,746	-60 Reduced 1.22%	4,846 $503,000
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $70,749 - $78,140	-646 Reduced 11.64%	4,906 $557,000
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $2,254 - $2,760	-25 Reduced 0.45%	5,552 $611,000
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $8,693 - $10,430	-91 Reduced 1.61%	5,577 $540,000
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $40,412 - $45,028	-401 Reduced 6.61%	5,668 $617,000
Q4 2022 Jan 20, 2023	BUY	$95.06 - $111.52 $5,418 - $6,356	57 Added 0.95%	6,069 $0
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $9,385 - $10,866	-97 Reduced 1.59%	6,012 $582,000
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $30,101 - $36,706	264 Added 4.52%	6,109 $723,000
Q3 2021 Oct 07, 2021	SELL	$116.66 - $129.06 $17,499 - $19,359	-150 Reduced 2.5%	5,845 $690,000
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $23,400 - $27,569	-215 Reduced 3.46%	5,995 $718,000
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $24,732 - $31,654	-323 Reduced 4.94%	6,210 $631,000
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $13,317 - $19,474	212 Added 3.35%	6,533 $594,000
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 1.56%	6,321 $549,000
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $16,368 - $17,748	-200 Reduced 3.02%	6,421 $537,000
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $9,110 - $10,625	-125 Reduced 1.85%	6,621 $557,000
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 1.46%	6,746 $539,000
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $3,278 - $3,713	-50 Reduced 0.73%	6,846 $495,000
Q3 2018 Oct 25, 2018	BUY	$60.81 - $73.36 $11,553 - $13,938	190 Added 2.83%	6,896 $494,000
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $4,777 - $5,114	-89 Reduced 1.31%	6,706 $383,000
Q3 2017 Oct 18, 2017	SELL	$48.06 - $53.64 $18,022 - $20,115	-375 Reduced 5.23%	6,795 $363,000
Q2 2017 Aug 08, 2017	BUY	N/A	7,170	7,170 $349,000

Others Institutions Holding ABT

# of Institutions

3,649

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Account

Newman Dignan & Sheerar, Inc. Abbott Laboratories Transaction History